Emami マネジメント

マネジメント基準チェック /34

Emamiの CEO はHarsha Agarwalで、 Apr2022年に任命され、の在任期間は 2.58年です。の年間総報酬は₹ 69.70Mで、 41.3%給与と58.7%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の0.13%を直接所有しており、その価値は₹ 348.33M 。経営陣と取締役会の平均在任期間はそれぞれ2.6年と17.3年です。

主要情報

Harsha Agarwal

最高経営責任者

₹69.7m

報酬総額

CEO給与比率	41.3%
CEO在任期間	2.6yrs
CEOの所有権	0.1%
経営陣の平均在職期間	2.6yrs
取締役会の平均在任期間	17.3yrs

経営陣の近況

Recent updates

CEO報酬分析

Emami の収益と比較して、Harsha Agarwal の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Sep 30 2024	n/a	n/a	₹8b
Jun 30 2024	n/a	n/a	₹7b
Mar 31 2024	₹70m	₹29m	₹7b
Dec 31 2023	n/a	n/a	₹7b
Sep 30 2023	n/a	n/a	₹7b
Jun 30 2023	n/a	n/a	₹7b
Mar 31 2023	₹62m	₹26m	₹6b
Dec 31 2022	n/a	n/a	₹9b
Sep 30 2022	n/a	n/a	₹8b
Jun 30 2022	n/a	n/a	₹8b
Mar 31 2022	₹13m	₹12m	₹8b
Dec 31 2021	n/a	n/a	₹6b
Sep 30 2021	n/a	n/a	₹6b
Jun 30 2021	n/a	n/a	₹5b
Mar 31 2021	₹12m	₹11m	₹5b
Dec 31 2020	n/a	n/a	₹4b
Sep 30 2020	n/a	n/a	₹3b
Jun 30 2020	n/a	n/a	₹3b
Mar 31 2020	₹12m	₹11m	₹3b
Dec 31 2019	n/a	n/a	₹3b
Sep 30 2019	n/a	n/a	₹3b
Jun 30 2019	n/a	n/a	₹3b
Mar 31 2019	₹11m	₹10m	₹3b
Dec 31 2018	n/a	n/a	₹3b
Sep 30 2018	n/a	n/a	₹3b
Jun 30 2018	n/a	n/a	₹3b
Mar 31 2018	₹8m	₹7m	₹3b

報酬と市場: Harshaの総報酬 ($USD 824.85K ) は、 Indian市場 ($USD 618.65K ) の同規模の企業の平均を上回っています。

報酬と収益: Harshaの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Harsha Agarwal (48 yo)

2.6yrs

在職期間

₹69,696,000

報酬

Mr. Harsha Vardhan Agarwal, B.Com., serves as Vice Chairman and Managing Director of Emami Limited since April 01, 2022 and had been its Whole-Time Director since January 15, 2005 until April 01, 2022. He...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Radhe Goenka	Founder & Non-Executive Chairman	30.5yrs	₹1.03m	0.60% ₹ 1.7b
Harsha Agarwal	MD & Vice Chairman	2.6yrs	₹69.70m	0.13% ₹ 353.5m
Mohan Goenka	Vice Chairman & Whole Time Director	19.8yrs	₹69.70m	0.26% ₹ 742.5m
Radhe Agarwal	Founder & Chairman Emeritus	no data	₹400.00k	0.084% ₹ 237.2m
Naresh Bhansali	CEO of Finance	no data	₹29.72m	データなし
Sandeep Sultania	Company Secretary & Compliance Officer and VP of Sales Commercial	1.5yrs	₹7.20m	データなし
Sushil Goenka	Whole-Time Director	2.6yrs	₹41.26m	0.34% ₹ 969.9m
Prashant Goenka	Whole-Time Director	no data	₹34.87m	0.099% ₹ 279.3m
Priti Sureka	Whole Time Director	no data	₹34.87m	3.78% ₹ 10.6b
Sanjay Madan	President of Operations	no data	データなし	データなし
Rajesh Sharma	President of Finance & Investor Relations	no data	データなし	データなし
Shagun Tulsyan	President of Legal & Revenue	no data	データなし	データなし

2.6yrs

平均在職期間

52yo

平均年齢

経験豊富な経営陣: 531162の経営陣は経験豊富であると考えられます ( 2.6年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Radhe Goenka	Founder & Non-Executive Chairman	30.5yrs	₹1.03m	0.60% ₹ 1.7b
Harsha Agarwal	MD & Vice Chairman	19.8yrs	₹69.70m	0.13% ₹ 353.5m
Mohan Goenka	Vice Chairman & Whole Time Director	19.8yrs	₹69.70m	0.26% ₹ 742.5m
Radhe Agarwal	Founder & Chairman Emeritus	30.5yrs	₹400.00k	0.084% ₹ 237.2m
Sushil Goenka	Whole-Time Director	29.5yrs	₹41.26m	0.34% ₹ 969.9m
Prashant Goenka	Whole-Time Director	10.8yrs	₹34.87m	0.099% ₹ 279.3m
Priti Sureka	Whole Time Director	14.8yrs	₹34.87m	3.78% ₹ 10.6b
Chandra Dhanuka	Non-Executive Independent Director	7.3yrs	₹1.52m	データなし
Aditya Agarwal	Non-Executive Director	19.8yrs	₹730.00k	0.25% ₹ 699.5m
Debabrata Sarkar	Non-Executive Independent Director	5.8yrs	₹1.58m	データなし
Mamta Binani	Independent Director	3.1yrs	₹1.10m	データなし
Anand Rathi	Independent Director	2.3yrs	₹1.02m	データなし

17.3yrs

平均在職期間

52yo

平均年齢

経験豊富なボード: 531162の取締役会は経験豊富で経験豊富です ( 17.3年の平均在任期間)。

Emami マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

Emami Limited, Annual General Meeting, Aug 27, 2024

Emami Limited Announces Change in Management

Emami Limited Announces Changes to the Senior Management Personnel

Insider recently bought ₹1.0m worth of stock

Emami Limited Announces Cessation of Mr. Vinod Rao, President-CCD, Personnel of Senior Management Effective from the Closing Hours of July 31, 2023

Emami Limited, Annual General Meeting, Aug 23, 2023

Recent updates

Price target decreased by 7.2% to ₹805

First half dividend of ₹4.00 announced

Second quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind

Emami Limited to Report Q2, 2025 Results on Nov 07, 2024

Emami Limited, Annual General Meeting, Aug 27, 2024

Price target increased by 8.3% to ₹777

First quarter 2025 earnings: EPS misses analyst expectations

Emami Limited to Report Q1, 2025 Results on Aug 01, 2024

Investor sentiment improves as stock rises 34%

Price target increased by 8.2% to ₹613

Full year 2024 earnings released: EPS: ₹16.55 (vs ₹14.50 in FY 2023)

Emami Limited (BSE:531162) signed a share purchase agreement to acquire 4.64% stake in Brillare Science Pvt. Ltd. from founder and other shareholders of Brillare Science Pvt. Ltd.

Dividend of ₹4.00 announced

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Emami Limited Approves Second Interim Dividend for the Financial Year 2023-24

Investor sentiment improves as stock rises 16%

Emami Limited Declares Interim Dividend for the Financial Year 2023-24

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Emami Limited (BSE:531162) completed the acquisition of 26% stake in Axiom Ayurveda Private Limited

Emami Limited (BSE:531162) entered into definitive agreement to acquire 26% stake in Axiom Ayurveda Private Limited.

Emami Limited Announces Change in Management

Manipal Health Enterprises Pvt Ltd acquired 84% stake in AMRI Hospitals Ltd. from Emami Limited (BSE:531162).

Manipal Health Enterprises Pvt Ltd acquired 84% stake in AMRI Hospitals Ltd. from Emami Limited (BSE:531162).

Emami Limited Announces Changes to the Senior Management Personnel

Insider recently bought ₹1.0m worth of stock

Emami May Seal AMRI Sale to Manipal Group This Month

Price target increased by 7.6% to ₹517

Emami Limited Announces Cessation of Mr. Vinod Rao, President-CCD, Personnel of Senior Management Effective from the Closing Hours of July 31, 2023

Full year 2023 earnings: EPS misses analyst expectations

Emami Limited to Report Q4, 2024 Results on May 30, 2024

Emami Limited Proposes Two Interim Dividends for the Financial Year 2022-23

Emami Limited, Annual General Meeting, Aug 23, 2023

Emami Limited to Report Q1, 2024 Results on Aug 07, 2023

Emami Limited Approves Executive Changes

Full year 2023 earnings: EPS misses analyst expectations

Price target decreased by 7.3% to ₹510

Third quarter 2023 earnings: EPS exceeds analyst expectations

Emami Limited Declares Second Interim Dividend for the Financial Year 2022-23

Emami Limited to Report Q3, 2023 Results on Feb 03, 2023

Max Healthcare Reportedly Eyeing AMRI Hospitals

Second quarter 2023 earnings: EPS exceeds analyst expectations

Second quarter 2023 earnings: EPS exceeds analyst expectations

Emami Limited Declares Interim Dividend for the Financial Year 2022-23

Emami Limited to Report Q2, 2023 Results on Nov 11, 2022

Emami Limited, Annual General Meeting, Sep 09, 2022

Consensus forecasts updated

First quarter 2023 earnings released: EPS: ₹1.67 (vs ₹1.75 in 1Q 2022)

Emami Limited (BSE:531162) acquired 30% stake in Cannis Lupus Services India Private Limited.

Emami Limited to Report Q1, 2023 Results on Jul 29, 2022

Full year 2022 earnings: EPS exceeds analyst expectations

Emami Limited Announces Executive Changes

Emami Limited (BSE:531162) acquired 19% equity stake in Tru Native F&B Private Limited.

Emami Limited (BSE:531162) announces an Equity Buyback for INR 1,620 million worth of its shares.

Emami Ltd Restructures Its Board, Effective April 1, 2022

Third quarter 2022 earnings: EPS exceeds analyst expectations

Emami Limited Announces Declaration of Second Interim Dividend

Second quarter 2022 earnings released: EPS ₹4.17 (vs ₹2.66 in 2Q 2021)

Upcoming dividend of ₹4.00 per share

Non-Executive Independent Director Rama Bijapurkar has left the company

First quarter 2022 earnings released: EPS ₹1.75 (vs ₹0.88 in 1Q 2021)

Price target increased to ₹619

Full year 2021 earnings released: EPS ₹10.23 (vs ₹6.67 in FY 2020)

New 90-day high: ₹502

Analysts increase EPS estimates to ₹9.78

Third quarter 2021 earnings released: EPS ₹4.70 (vs ₹3.18 in 3Q 2020)

Revenue and earnings beat expectations

Price target raised to ₹510

New 90-day high: ₹451

New 90-day high: ₹401

マネジメント基準チェック /34

Emami Limited to Hit the Indian Market with Its Newest Offering Emasol-A Complete Range for Home Hygiene Products